Eli Lilly and Company and Slimming World provided sponsorship funding to support the creation of the ICS Weight Management Services Hub and have had no input into the organisation or content of this website.

Mid and South Essex

Question 1

Yes. Details of all weight management services available in MSE and associated policies can be found on the MSE ICB website.

Question 2

The Mid and South Essex ICB commissioned Tier 3 specialist weight management service was closed to referrals from January 2024 to March 2025. We are therefore unable to provide this information for the most recent full financial year.

These statistics are for Tier 4 :

a) IMD

Least deprived 10% <7
Less deprived 10-20% 9
Less deprived 20-30% <7
Less deprived 30-40% 7
Less deprived 40-50% <7
More deprived 10-20% 9
More deprived 20-30% <7
More deprived 30-40% 10
More deprived 40-50% 7
Most deprived 10% 7

b) Ethnicity

White - British 43
White - Irish <7
White - Any other White background <7
Mixed - White and Black Caribbean <7
Mixed - White and Black African <7
Mixed - White and Asian <7
Mixed - Any other mixed background <7
Asian or Asian British - Indian <7
Asian or Asian British - Pakistani <7
Asian or Asian British - Bangladeshi <7
Asian or Asian British - Any other Asian background <7
Black or Black British - Caribbean <7
Black or Black British - African <7
Black or Black British - Any other Black background <7
Other Ethnic Groups - Chinese <7
Other Ethnic Groups - Any other ethnic group <7
Not stated   9

c) Age

20-29 <7
30-39 30
40-49 15
50-59 16
60-69 <7

d) Sex

Male 11
Female 57

Question 3

Neighbourhood health plans are currently being developed. Weight management services will continue to be accessed through existing pathways.

No partnerships with Health Innovation Network.

Question 4

Tier 3 specialist weight management services contract value (3-year contract 2025-2028 including both service and drug costs): £4,457,130

National funding allocated to ICBs for the implementation of the NICE funding variation for the management of obesity for the prioritised patient cohort outlined in the NHSE interim commissioning guidance PRN01879-interim-commissioning-guidance-implementation-of-the-nice-technology-appraisal-ta1026-and-the-NICE-fu.pdf
2025/26: £606,000

Tier 4: No ringfenced budget specifically for this.  Annual forecast expenditure is £655k
None of the above budgets are ringfenced.